Skip to content 
EBOO therapy for autoimmune conditions is one of the most common questions we hear from patients living with lupus, rheumatoid arthritis, Hashimoto’s, multiple sclerosis, and other autoimmune diagnoses. The question behind it is almost always the same: Is there a way to calm my immune system without shutting it down entirely?
That question points to the most important distinction in this conversation. Conventional autoimmune drugs suppress the immune system. EBOO’s proposed mechanism is different. It aims to modulate the immune response, rebalancing it rather than disabling it. The difference matters.
But honest context matters too. EBOO therapy for autoimmune conditions has zero clinical trials behind it. Every proposed benefit is extrapolated from the broader ozone therapy research. This guide explains what the science actually supports, where the evidence stops, and how to decide whether EBOO could fit alongside your existing treatment.
If you are new to EBOO, start with what EBOO therapy is. This article focuses specifically on the autoimmune question.
If you have an autoimmune condition, your immune system is not weak. It is overactive. It has lost the ability to distinguish between foreign threats and your own tissue, so it attacks both.
Most conventional autoimmune medications suppress this overactive response. Corticosteroids, biologics, and immunosuppressants reduce the immune attack on your tissues. They work, and for many patients they are essential. But they come with a trade-off: by suppressing the entire immune system, they also reduce your ability to fight infections, heal wounds, and respond to genuine threats.
This is the side effect burden that drives autoimmune patients to explore complementary options. Not because their medications are bad, but because they want to reduce the collateral damage.
EBOO therapy for autoimmune conditions proposes a different mechanism. Instead of turning the immune system down, ozone’s documented effect is to rebalance it. The NRF2 pathway it activates upregulates antioxidant defenses, while the NF-kB pathway it suppresses reduces pro-inflammatory cytokine production. Based on ozone research, the result is immune modulation rather than immune suppression.
The proposed benefit of EBOO therapy for autoimmune conditions works through three mechanisms. The strength of evidence varies for each.
When ozone contacts blood during EBOO, it creates lipid ozonation products that activate the NRF2 pathway. NRF2 is your body’s master antioxidant switch. Once activated, it upregulates superoxide dismutase, catalase, and glutathione, your three primary internal antioxidant defenses.
For autoimmune patients, this matters because oxidative stress is a documented driver of autoimmune flares. NRF2 dysfunction has been specifically linked to lupus, rheumatoid arthritis, and scleroderma in published research. Restoring NRF2 activity is a legitimate therapeutic target.
A 2017 study on multiple sclerosis patients found that ozone therapy significantly reduced TNF-α and IL-1β while activating NRF2 phosphorylation. This is the strongest published evidence for ozone’s immunomodulatory effect.
The NRF2/NF-kB mechanism is explained in detail in EBOO therapy for chronic inflammation: how it works and what the evidence shows.
NF-kB is the master inflammatory switch. In autoimmune conditions, it is chronically overactivated, driving excess production of TNF-a, IL-6, and IL-1β. These cytokines are the molecules that tell your immune system to keep attacking.
Ozone therapy’s documented effect of suppressing NF-kB reduces this inflammatory signaling. A 2020 psoriasis study showed that ozone attenuated NF-kB and Th17 activation, both central to autoimmune skin inflammation.
The key distinction: this suppresses the inflammatory signaling pathway, not the immune system itself. Your ability to fight infections and heal remains intact.
EBOO adds a filtration component that standard ozone therapy lacks. The dialysis-like filter removes inflammatory proteins, immune complexes, and oxidized debris from the blood during the session.
For autoimmune patients with high circulating inflammatory loads, practitioners most often cite this physical removal of debris as potentially beneficial. Whether it produces clinically meaningful improvement remains unstudied.
What the filter captures is detailed in what EBOO filters actually capture from your blood.
EBOO therapy for autoimmune conditions is most commonly asked about by patients with rheumatoid arthritis, lupus, Hashimoto’s thyroiditis, multiple sclerosis, psoriasis, and inflammatory bowel disease. Here is where the evidence stands for each.
The pattern is consistent across every condition. The ozone therapy mechanism (NRF2/NF-kB) is relevant to autoimmune inflammation. Published studies exist for some conditions. But EBOO specifically has zero clinical trials for any of them.
This does not mean EBOO cannot help. It means the level of certainty is lower than many clinic websites suggest. An honest clinic tells you this upfront.
EBOO will not cure your autoimmune condition. No therapy can reverse the underlying immune dysregulation that causes autoimmunity. Management, not cure, is the realistic goal.
EBOO will not replace your medications. If you are on biologics, DMARDs, corticosteroids, or thyroid replacement, EBOO is a complement to those treatments, never a substitute. Any clinic that tells you to stop your medications in favor of EBOO is putting your health at risk.
EBOO will not work for everyone. Some autoimmune patients report meaningful improvement. Others notice minimal change. Three sessions are the standard evaluation point.
For the full contraindication list, read EBOO therapy contraindications: who should not have it.
EBOO therapy for autoimmune conditions tends to make the most sense for patients with a confirmed diagnosis from a specialist, who are already on established conventional treatment, continue to experience symptoms despite standard care, can afford the investment without financial strain, and have a treating physician who is aware of and supports exploring adjunct options.
At Purefico Medspa and Longevity Center in Cornelius, NC, we require autoimmune patients to work with a treating specialist before beginning EBOO. We coordinate care rather than replacing it.
I understand the frustration of living with an autoimmune condition. The medications often help but come with side effects that feel like a second illness. The desire to find something that supports your body without adding to the burden is completely reasonable.
What I can promise is honesty. EBOO may help. It may not. But I will never oversell it, and I will never tell you to stop your prescribed medications. If EBOO is right for you, we will figure that out together with your treating physician. If it is not, I will tell you that too.
If you are living with an autoimmune condition and considering EBOO as a complementary approach, book a consultation with our team. We will review your diagnosis, coordinate with your specialist, and give you an honest assessment.
You can also read how to choose an EBOO provider: 9 questions to ask, or learn about our EBOO therapy service in Cornelius, NC.
EBOO therapy for autoimmune conditions is being explored as an adjunct therapy based on ozone’s documented immunomodulatory effects. The mechanism (NRF2 activation, NF-kB suppression) is relevant to autoimmune inflammation. However, zero clinical trials have studied EBOO specifically for any autoimmune condition. Results vary by patient.
No. EBOO’s proposed mechanism is immunomodulation, not immunosuppression. It aims to rebalance the immune response by reducing overactive inflammatory signaling while preserving protective immunity. This is fundamentally different from conventional immunosuppressant medications.
In most cases, yes. EBOO therapy for autoimmune conditions can be used alongside prescribed medications including biologics, DMARDs, and corticosteroids. However, your EBOO provider must review your full medication list, especially anticoagulants. Never change your medications based on EBOO results without consulting your prescribing physician.
Most practitioners recommend at least three sessions to assess response, typically one to two weeks apart. Autoimmune patients may need a longer initial course than general wellness patients. Your provider should evaluate your response after three sessions.
No. EBOO is classified as experimental and elective by all major insurance carriers. A typical course of three to six sessions costs between $750 and $4,800 out of pocket. HSA and FSA funds may be eligible.
No controlled data can answer this definitively. Based on the ozone research and practitioner observations, conditions driven primarily by inflammatory cytokine overproduction, such as rheumatoid arthritis, lupus, and multiple sclerosis, have the strongest theoretical case. But individual responses vary significantly.
Yes. Purefico Medspa and Longevity Center in Cornelius, near Charlotte, offers EBOO therapy for autoimmune patients who are working with a treating specialist. We require a consultation and coordination with your physician before beginning sessions.
1. Re L, et al. Medical ozone promotes NRF2 phosphorylation, reducing oxidative stress and pro-inflammatory cytokines in multiple sclerosis patients. European Journal of Pharmacology. 2017;811:148-154.
2. Zeng J, et al. Ozone therapy attenuates NF-kB-mediated local inflammatory response and Th17 cells in psoriasis. International Journal of Biological Sciences. 2020;16(12):2116-2130.
3. Viebahn-Haensler R, Leon Fernandez OS. Ozone in medicine: low-dose ozone in chronic inflammatory diseases. International Journal of Molecular Sciences. 2021;22(15):7890.
4. Marchegiani A, et al. The Nrf2-antioxidant response element signaling pathway and scleroderma. International Journal of Molecular Sciences. 2018;19(5):1471.
5. Di Paolo N, Bocci V, Salvo DP, et al. EBOO: a controlled trial in peripheral artery disease. International Journal of Artificial Organs. 2005;28(10):1039-1050.
6. Bocci V, Zanardi I, Travagli V. Ozone hormetic dose-response. Journal of Translational Medicine. 2011;9:66.
7. Cacciatore S, et al. Effectiveness and safety of ozone therapy: an umbrella review. Medicina. 2026;14(2):289.
8. U.S. Food and Drug Administration. 21 CFR 801.415, Maximum acceptable level of ozone.
Melissa Lynch, NP, is a nurse practitioner with 28 years of clinical experience and the founder of Purefico MedSpa & Therapy, with locations in Cornelius and Archdale, North Carolina.
